Contact

Get In Touch With Us

Medexus Pharmaceuticals Inc. endeavors to share all the information that our investors require in order to make informed investment decisions. For questions regarding our business operations, partnerships, our product pipeline/portfolio, or for general inquiries, please reach out us using the form provided.

Medexus Pharmaceuticals, Inc.
1 Place du Commerce
Suite 225
Verdun, QC H3E 1A2
Canada

Ken d’Entremont
Chief Executive Officer and Director

ken.dentremont@medexus.com
905-676-0800

Roland Boivin
Chief Financial Officer

roland.boivin@medexus.com
514-762-2626 ext. 202

Investor Relations (US)

Crescendo Communications, LLC
David Waldman / Natalya Rudman

mdp@crescendo-ir.com
212-671-1020

Investor Relations (Canada)

Tina Byers
Adelaide Capital
Tel: 905-330-3275
E-mail: tina@adcap.ca

Direct Financial Strategies and Communication Inc.
Frank Candido

frank.candido@medexus.com
514-969-5530

USA: For adverse events, medical inquiries, and product-related concerns, please call 1-855-336-3322.

Canada: For adverse events, medical inquiries, and product-related concerns, please call 1-877-633-3987 or by written at  MedexusPV@innomar-strategies.com.